Literature DB >> 16267056

Seven-transmembrane receptor signaling through beta-arrestin.

Sudha K Shenoy1, Robert J Lefkowitz.   

Abstract

Cell surface receptors are important communicators of external stimuli to the cell interior where they lead to initiation of various signaling pathways and cellular responses. The largest receptor family is the seven-transmembrane receptor (7TMR) family, with approximately 1000 coding genes in the human genome. When 7TMRs are stimulated with agonists, they activate heterotrimeric guanine nucleotide-binding proteins (G proteins), leading to the production of signaling second messengers, such as adenosine 3',5'-monophosphate, inositol phosphates, and others. Activated receptors are rapidly phosphorylated on serine and threonine residues by specialized enzymes called G protein-coupled receptor kinases. Phosphorylated receptors bind the multifunctional adaptor proteins beta-arrestin1 and beta-arrestin2 with high affinity. Beta-arrestin binding blocks further G protein coupling, leading to "desensitization" of G protein-dependent signaling pathways. For several years, this was considered the sole function of beta-arrestins. However, novel functions of beta-arrestins have been discovered. Beta-arrestins are now designated as important adaptors that link receptors to the clathrin-dependent pathway of internalization. Beta-arrestins bind and direct the activity of several nonreceptor tyrosine kinases in response to 7TMR stimulation. Beta-arrestins also bind and scaffold members of such signaling cascades as the mitogen-activated protein kinases (MAPKs). Beta-arrestins are crucial components in 7TMR signaling leading to cellular responses that include cell survival and chemotaxis. Beta-arrestins act as endocytic adaptors and signal mediators not only for the 7TMRs, but also for several receptor tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267056     DOI: 10.1126/stke.2005/308/cm10

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  80 in total

1.  Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics.

Authors:  Jason D Hoffert; Trairak Pisitkun; Fahad Saeed; Jae H Song; Chung-Lin Chou; Mark A Knepper
Journal:  Mol Cell Proteomics       Date:  2011-11-21       Impact factor: 5.911

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 4.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

Review 5.  GPCR signaling along the endocytic pathway.

Authors:  Roshanak Irannejad; Mark von Zastrow
Journal:  Curr Opin Cell Biol       Date:  2013-12-28       Impact factor: 8.382

6.  Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Authors:  Marta Busnelli; Aude Saulière; Maurice Manning; Michel Bouvier; Celine Galés; Bice Chini
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

7.  ERαΔ4, an ERα splice variant missing exon4, interacts with caveolin-3 and mGluR2/3.

Authors:  Angela M Wong; Alexandra K Scott; Caroline S Johnson; Margaret A Mohr; Melinda Mittelman-Smith; Paul E Micevych
Journal:  J Neuroendocrinol       Date:  2019-05-23       Impact factor: 3.627

8.  Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.

Authors:  Jiyuan Sun; Xin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

9.  beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.

Authors:  Cédric Boularan; Mark G H Scott; Karima Bourougaa; Myriam Bellal; Emmanuel Esteve; Alain Thuret; Alexandre Benmerah; Marc Tramier; Maité Coppey-Moisan; Catherine Labbé-Jullié; Robin Fåhraeus; Stefano Marullo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-05       Impact factor: 11.205

10.  Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.

Authors:  Cecilea C Clayton; Mei Xu; Charles Chavkin
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.